10,949 Shares in The Clorox Company $CLX Acquired by Blackhawk Capital Partners LLC

Blackhawk Capital Partners LLC purchased a new position in shares of The Clorox Company (NYSE:CLX) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 10,949 shares of the company’s stock, valued at approximately $1,350,000.

Other large investors also recently bought and sold shares of the company. Vanguard Group Inc. increased its holdings in shares of Clorox by 1.7% during the 2nd quarter. Vanguard Group Inc. now owns 15,845,496 shares of the company’s stock worth $1,902,569,000 after buying an additional 272,420 shares during the last quarter. Invesco Ltd. grew its position in Clorox by 138.3% during the second quarter. Invesco Ltd. now owns 3,245,175 shares of the company’s stock valued at $389,648,000 after acquiring an additional 1,883,465 shares during the period. Norges Bank acquired a new stake in Clorox during the second quarter worth about $190,429,000. Arrowstreet Capital Limited Partnership raised its holdings in shares of Clorox by 218.4% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,249,127 shares of the company’s stock worth $149,983,000 after purchasing an additional 856,873 shares during the period. Finally, ProShare Advisors LLC raised its holdings in shares of Clorox by 7.0% in the 2nd quarter. ProShare Advisors LLC now owns 1,160,881 shares of the company’s stock worth $139,387,000 after purchasing an additional 75,514 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

Clorox stock opened at $113.46 on Friday. The Clorox Company has a 12-month low of $96.66 and a 12-month high of $164.22. The company has a debt-to-equity ratio of 18.01, a current ratio of 0.76 and a quick ratio of 0.50. The company has a market capitalization of $13.84 billion, a price-to-earnings ratio of 17.81, a price-to-earnings-growth ratio of 0.56 and a beta of 0.58. The firm’s fifty day moving average price is $103.80 and its 200 day moving average price is $114.86.

Clorox (NYSE:CLX) last announced its earnings results on Monday, November 3rd. The company reported $0.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The business had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. During the same period in the previous year, the company earned $1.86 earnings per share. The company’s revenue for the quarter was down 18.9% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, research analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 28th will be given a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, January 28th. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.4%. Clorox’s dividend payout ratio (DPR) is presently 77.86%.

Insider Activity

In related news, Director Pierre R. Breber purchased 4,000 shares of the business’s stock in a transaction that occurred on Friday, November 21st. The shares were purchased at an average cost of $104.13 per share, with a total value of $416,520.00. Following the completion of the acquisition, the director directly owned 13,000 shares of the company’s stock, valued at approximately $1,353,690. The trade was a 44.44% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.63% of the company’s stock.

Clorox News Summary

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Clorox agreed to acquire GOJO Industries, the maker of Purell, for $2.25 billion in cash — a strategic push deeper into skin health and hygiene that management says is growth‑accretive and advances its IGNITE plan. The deal expands Clorox’s consumer and professional hygiene footprint and is the primary catalyst for today’s stock strength. Clorox Announces Acquisition of GOJO
• Positive Sentiment: Management updated FY‑2026 EPS guidance to $5.95–$6.30, slightly above consensus, and reiterated revenue targets — a sign the company expects the combined portfolio and cost initiatives to help stabilize growth. This guidance helped reassure investors even as organic revenue pressures persist. (Company guidance release)
• Neutral Sentiment: Deutsche Bank raised its price target on CLX to $114 (keeps a Hold rating), a small incremental positive that signals modest upside in analysts’ view but not a strong buy signal. Deutsche Bank Raises Price Target
• Neutral Sentiment: Broad media and analyst coverage (WSJ, CNBC, MarketWatch) has amplified the deal’s reach and provided investors with deal details and management commentary — increasing attention but not resolving long‑term execution questions. WSJ: Clorox to Buy Purell-Maker
• Negative Sentiment: Some sell‑side skepticism remains: Barclays kept an Underweight (sell) stance despite a small target tweak, and commentary from critics highlights valuation and fundamental concerns that could limit upside until integration is proven. Barclays Remains a Sell
• Negative Sentiment: The deal is being financed with debt, increasing leverage and short‑term balance‑sheet risk; investors will watch integration execution and cost synergy realization closely — these risks are why some analysts remain cautious. WSJ: Deal Financed with Debt
• Negative Sentiment: Critical commentary (e.g., Seeking Alpha) questions whether the acquisition meaningfully fixes Clorox’s underlying growth challenges and suggests the company still needs stronger organic execution — a narrative that could cap the stock if results don’t improve. Seeking Alpha: Adding Sanitizers, But In Need Of Getting Its Hands Dirty

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the stock. Zacks Research raised shares of Clorox from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. Bank of America dropped their price objective on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a research report on Wednesday, October 8th. UBS Group cut their target price on shares of Clorox from $119.00 to $115.00 and set a “neutral” rating on the stock in a research note on Wednesday, January 14th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Clorox from $110.00 to $114.00 and gave the stock a “hold” rating in a research report on Friday. Finally, BNP Paribas Exane cut their price objective on Clorox from $103.00 to $101.00 and set an “underperform” rating on the stock in a research report on Friday, January 16th. One research analyst has rated the stock with a Buy rating, thirteen have assigned a Hold rating and four have given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Reduce” and an average price target of $122.19.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.